EnrichedResearchLab
How a Google DeepMind Spin-off Hunts Hidden Drug Targets
For more than a decade, artificial intelligence has been touted as a way to dramatically accelerate drug discovery . Yet despite billions of dollars in investment, relatively few AI-designed medicines have made
Why it matters
This story from IEEE Spectrum AI is relevant to the Research branch of the AI ecosystem and may affect models, products, or research direction.
Technical breakdown
For more than a decade, artificial intelligence has been touted as a way to dramatically accelerate drug discovery . Yet despite billions of dollars in investment, relatively few AI-designed medicines have made
Business impact
Watch for product launches, funding moves, or policy shifts tied to this headline.